Arrowhead Pharmaceuticals, Inc. (ARWR) financial statements and ratios from SEC XBRL: revenue $0.5B (TTM), net margin -0.2%, revenue growth 171.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $829.45M |
| Revenue (TTM) | $0.5B |
| Net Margin | -0.2% |
| Operating Margin (TTM) | -118.3% |
| Revenue Growth (YoY) | 171.0% |
| EPS Growth (YoY) | 7.9% |
| FCF Growth (YoY) | -161.2% |
| Price / Book | 26.41 |
| Price / Sales | 25.29 |
| FCF Yield | 0.9% |
| Altman Z-Score | 7.89 (safe) |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| Sector P/E (Healthcare) | 21.7 |
ARWR overview · ARWR earnings · ARWR KPIs · ARWR documents · ARWR ownership · ARWR peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.